Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Baakman AC"'
Autor:
Groeneveld Gj, Baakman Ac, Broekhuizen K, Cohen A, Lemstra E, Schoonenboom N, Gerven Jv, Doeselaar Lv, Kalisvaart K, Kam, Gavan C, Camps L, Bajenaru O, Swart E, Scheltens P
Publikováno v:
British Journal of Clinical Pharmacology. Wiley-Blackwell
British Journal of Clinical Pharmacology, 88(6), 2814-2829. WILEY
Baakman, A C, Gavan, C, van Doeselaar, L, de Kam, M, Broekhuizen, K, Bajenaru, O, Camps, L, Swart, E L, Kalisvaart, K, Schoonenboom, N, Lemstra, E, Scheltens, P, Cohen, A, van Gerven, J & Groeneveld, G J 2021, ' Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease ', British Journal of Clinical Pharmacology . https://doi.org/10.1111/bcp.15206, https://doi.org/10.1111/bcp.15206
British Journal of Clinical Pharmacology, 88(6), 2814-2829. WILEY
Baakman, A C, Gavan, C, van Doeselaar, L, de Kam, M, Broekhuizen, K, Bajenaru, O, Camps, L, Swart, E L, Kalisvaart, K, Schoonenboom, N, Lemstra, E, Scheltens, P, Cohen, A, van Gerven, J & Groeneveld, G J 2021, ' Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease ', British Journal of Clinical Pharmacology . https://doi.org/10.1111/bcp.15206, https://doi.org/10.1111/bcp.15206
Aims Cholinesterase inhibitors (CEIs) have been shown to improve cognitive functioning in Alzheimer's disease (AD) patients, but are associated with multiple side effects and only 20-40% of the patients clinically improve. In this study, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef9c34848808f69e7675427390ea1695
https://pubmed.ncbi.nlm.nih.gov/34964149
https://pubmed.ncbi.nlm.nih.gov/34964149
Autor:
Baakman AC; Centre for Human Drug Research, Leiden, The Netherlands., Gavan C; Clinicii de neurologie a Spitalului Universitar de Urgenta, Bucharest, Romania., van Doeselaar L; Centre for Human Drug Research, Leiden, The Netherlands., de Kam M; Centre for Human Drug Research, Leiden, The Netherlands., Broekhuizen K; Centre for Human Drug Research, Leiden, The Netherlands., Bajenaru O; Clinicii de neurologie a Spitalului Universitar de Urgenta, Bucharest, Romania., Camps L; Centre for Human Drug Research, Leiden, The Netherlands., Swart EL; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Amsterdam, The Netherlands., Kalisvaart K; Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands., Schoonenboom N; Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands., Lemstra E; Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Scheltens P; Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Cohen A; Centre for Human Drug Research, Leiden, The Netherlands., van Gerven J; Centre for Human Drug Research, Leiden, The Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jun; Vol. 88 (6), pp. 2814-2829. Date of Electronic Publication: 2022 Jan 26.
Autor:
Baakman AC; Centre for Human Drug Research, Leiden, Netherlands., Zuiker R; Centre for Human Drug Research, Leiden, Netherlands., van Gerven JMA; Centre for Human Drug Research, Leiden, Netherlands., Gross N; Research and Development Teva Pharmaceuticals, Frazer, Philadelphia, USA., Yang R; Research and Development Teva Pharmaceuticals, Frazer, Philadelphia, USA., Fetell M; Research and Development Teva Pharmaceuticals, Frazer, Philadelphia, USA., Gershon A; Global Patient Safety and Pharmacovigilance, Teva Pharmaceuticals, Petah Tikva, Israel.; Formerly Global Patient Safety and Pharmacovigilance, Teva Pharmaceuticals, Petah Tikva, Israel., Gilgun-Sherki Y; Formerly Research and Development Teva Pharmaceuticals, Netanya, Israel., Hellriegel E; Research and Development Teva Pharmaceuticals, West Chester, Pennsylvania, USA., Spiegelstein O; Research and Development Teva Pharmaceuticals, Netanya, Israel.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 May; Vol. 85 (5), pp. 970-985. Date of Electronic Publication: 2019 Mar 14.
Autor:
Baakman AC; Centre for Human Drug Research, Leiden, the Netherlands., Alvarez-Jimenez R; Centre for Human Drug Research, Leiden, the Netherlands., Loewen G; Forum Pharmaceuticals, Waltham, USA., de Kam ML; Centre for Human Drug Research, Leiden, the Netherlands., Broekhuizen K; Centre for Human Drug Research, Leiden, the Netherlands., Hilt DC; Forum Pharmaceuticals, Waltham, USA., Groeneveld GJ; Centre for Human Drug Research, Leiden, the Netherlands.
Publikováno v:
Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2019 Apr 01; Vol. 5, pp. 89-98. Date of Electronic Publication: 2019 Apr 01 (Print Publication: 2019).
Autor:
van Amerongen G; Centre for Human Drug Research, Leiden, the Netherlands. Electronic address: GvAmerongen@chdr.nl., Kanhai K; Centre for Human Drug Research, Leiden, the Netherlands., Baakman AC; Centre for Human Drug Research, Leiden, the Netherlands., Heuberger J; Centre for Human Drug Research, Leiden, the Netherlands., Klaassen E; Centre for Human Drug Research, Leiden, the Netherlands., Beumer TL; Echo Pharmaceuticals, Weesp, the Netherlands., Strijers RLM; Department of Neurology and Clinical Neurophysiology, VU University Medical Center, Amsterdam, the Netherlands., Killestein J; Department of Neurology and Clinical Neurophysiology, VU University Medical Center, Amsterdam, the Netherlands., van Gerven J; Centre for Human Drug Research, Leiden, the Netherlands., Cohen A; Centre for Human Drug Research, Leiden, the Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, the Netherlands; Department of Neurology and Clinical Neurophysiology, VU University Medical Center, Amsterdam, the Netherlands.
Publikováno v:
Clinical therapeutics [Clin Ther] 2018 Sep; Vol. 40 (9), pp. 1467-1482. Date of Electronic Publication: 2017 Feb 09.
Autor:
Baakman AC; Centre for Human Drug Research, Leiden, The Netherlands., Alvarez-Jimenez R; Centre for Human Drug Research, Leiden, The Netherlands., Rissmann R; Centre for Human Drug Research, Leiden, The Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, The Netherlands., Stevens J; Centre for Human Drug Research, Leiden, The Netherlands., Goulooze SC; Centre for Human Drug Research, Leiden, The Netherlands., den Burger JCG; Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, The Netherlands., Swart EL; Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, The Netherlands., van Gerven JMA; Centre for Human Drug Research, Leiden, The Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2017 Aug; Vol. 83 (8), pp. 1676-1687. Date of Electronic Publication: 2017 Apr 08.
Autor:
Alvarez-Jimenez R; 1 Centre for Human Drug Research, Leiden, the Netherlands., Baakman AC; 1 Centre for Human Drug Research, Leiden, the Netherlands., Stevens J; 1 Centre for Human Drug Research, Leiden, the Netherlands., Goulooze SC; 1 Centre for Human Drug Research, Leiden, the Netherlands.; 2 Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Hart EP; 1 Centre for Human Drug Research, Leiden, the Netherlands., Rissmann R; 1 Centre for Human Drug Research, Leiden, the Netherlands., van Gerven JM; 1 Centre for Human Drug Research, Leiden, the Netherlands.; 3 Neurology Department, Leiden University Medical Centre, Leiden, the Netherlands., Groeneveld GJ; 1 Centre for Human Drug Research, Leiden, the Netherlands.; 4 Neurology Department, VU University Medical Centre, Amsterdam, the Netherlands.
Publikováno v:
Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2017 Feb; Vol. 31 (2), pp. 192-203. Date of Electronic Publication: 2016 Dec 09.
Autor:
Alvarez-Jimenez R; Centre for Human Drug Research, 2333, CL, Leiden, the Netherlands. ralvarez@chdr.nl., Groeneveld GJ; Centre for Human Drug Research, 2333, CL, Leiden, the Netherlands.; Neurology Department, VU University Medical Center, 1081, HV, Amsterdam, the Netherlands., van Gerven JM; Centre for Human Drug Research, 2333, CL, Leiden, the Netherlands.; Neurology Department, Leiden University Medical Center, 2333, ZA, Leiden, the Netherlands., Goulooze SC; Centre for Human Drug Research, 2333, CL, Leiden, the Netherlands.; Leiden Academic Center for Drug Research, Division of Pharmacology, Faculty of Mathematics and Natural Sciences, Leiden University, 2333, CC, Leiden, the Netherlands., Baakman AC; Centre for Human Drug Research, 2333, CL, Leiden, the Netherlands., Hay JL; Centre for Human Drug Research, 2333, CL, Leiden, the Netherlands., Stevens J; Centre for Human Drug Research, 2333, CL, Leiden, the Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Oct; Vol. 82 (4), pp. 1011-21. Date of Electronic Publication: 2016 Jul 14.
Autor:
Baakman AC; Centre for Human Drug Research, Leiden, The Netherlands., 't Hart E; Centre for Human Drug Research, Leiden, The Netherlands., Kay DG; Neurodyn Life Sciences, Charlottetown, Prince Edward Island, Canada., Stevens J; Centre for Human Drug Research, Leiden, The Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, The Netherlands., Maelicke A; Neurodyn Life Sciences, Charlottetown, Prince Edward Island, Canada.; Galantos Pharma, Nieder-Olm, Germany., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.
Publikováno v:
Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2016 Jan 20; Vol. 2 (1), pp. 13-22. Date of Electronic Publication: 2016 Jan 20 (Print Publication: 2016).
Autor:
Verberne WR; UMC Utrecht, Rudolf Magnus Institute of Neuroscience, Utrecht, the Netherlands., Snijders TJ, Liem KS, Baakman AC, Veldhuijzen DS
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2013; Vol. 157 (5), pp. A5434.